Immunotherapy Indications Withdrawn In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs? by Anna Goshua New Tactics for Bladder Cancer After decades without treatment advances, options for patients with bladder cancer are now more numerous. by Kendall K. Morgan Survivor Profile Hope and Endurance Bladder cancer survivor Randy Layne and his wife, Ellen, faced his diagnosis, treatment and recovery together. by Martha Irvine Yesterday & Today Who Loves Ya, Baby? Telly Savalas met his match in bladder cancer. Earlier diagnosis and more aggressive treatment might have made a difference. by Jocelyn Selim Cancer Talk Rethinking Access to Disability Benefits Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments. by Jen Tota McGivney Expanding Immunotherapy At a patient advocate event, researchers discussed how to extend the benefits of immunotherapy to more people. by Kevin McLaughlin Should All Kids With Cancer Get Genetic Testing? Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members. by Marcus A. Banks Understanding How Radiation Causes Cancer Researchers are investigating who is at greatest risk for radiation-induced cancers. by Kate Yandell More Posts